BioBrit appeared to be the Corporate Investor, which was created in 2012.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the BioBrit, startups are often financed by Silicon Valley Bank, Sears Capital Management, Oxford Finance LLC. The meaningful sponsors for the fund in investment in the same round are Sears Capital Management, NEXT Frontier Capital, Mission Bay Capital. In the next rounds fund is usually obtained by Sears Capital Management, NEXT Frontier Capital, Mission Bay Capital.
Among the most popular fund investment industries, there are Therapeutics, Medical. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight SiteOne Therapeutics, Castle Biosciences.
The increased amount of exits for fund were in 2019. The common things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2018. This BioBrit works on 4 percentage points less the average amount of lead investments comparing to the other organizations.
Related Funds
Fund Name | Location |
Cognitive Investment | - |
Copper Wire Ventures | - |
ETCapital | Cambridge, Cambridgeshire, United Kingdom |
Fuji Xerox | Auckland, Auckland, New Zealand |
Gaspar Global Ventures | New York, New York, United States |
IR Robotics | Chiyoda, Japan |
Porto Seguro | Brazil, São Paulo, Sao Paulo |
Shenzhen Runiu Touzi | China, Guangdong, Shenzhen |
Yuandian Maoyi | China, Shanghai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Creyon Bio | $40M | 08 Mar 2022 | San Diego, California, United States | ||
Amplo Biotechnology | 06 Oct 2021 | Pompano Beach, Florida, United States | |||
Stuart Therapeutics | $11M | 19 Mar 2021 | Florida, United States | ||
Primmune Therapeutics | $27M | 27 Oct 2020 | San Diego, California, United States | ||
Primmune Therapeutics | $7M | 02 Mar 2020 | San Diego, California, United States | ||
Compass Therapeutics | 11 Jul 2017 | Boston, Massachusetts, United States | |||
SiteOne Therapeutics | $15M | 06 Jan 2017 | Bozeman, Montana, United States | ||
SiteOne Therapeutics | $1M | 24 Sep 2014 | Bozeman, Montana, United States |
– Stuart Therapeutics from Stuart, Florida develops peptide therapeutics for ophthalmic diseases.
– The company raised $11m in Series A funding.
– The round was led by InFocus Capital Partners, with participation from the Wisconsin Alumni Research Foundation (WARF), MiMo Capital and BioBrit.
– The proceeds from the round will fund Phase 2 clinical trials for the company’s proprietary reparative therapeutic candidate, ST-100.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Creyon Bio | $40M | 08 Mar 2022 | San Diego, California, United States | ||
Amplo Biotechnology | 06 Oct 2021 | Pompano Beach, Florida, United States | |||
Stuart Therapeutics | $11M | 19 Mar 2021 | Florida, United States | ||
Primmune Therapeutics | $27M | 27 Oct 2020 | San Diego, California, United States | ||
Primmune Therapeutics | $7M | 02 Mar 2020 | San Diego, California, United States | ||
Compass Therapeutics | 11 Jul 2017 | Boston, Massachusetts, United States | |||
SiteOne Therapeutics | $15M | 06 Jan 2017 | Bozeman, Montana, United States | ||
SiteOne Therapeutics | $1M | 24 Sep 2014 | Bozeman, Montana, United States |